Intended for healthcare professionals

Rapid response to:

Clinical Review

Diagnosis and management of scalp ringworm

BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7388.539 (Published 08 March 2003) Cite this as: BMJ 2003;326:539

Rapid Response:

Terbinafine and Itraconazole should be licensed for use in children

I enjoyed reading the article on the diagnosis and management of
scalp ringworm. The increase in the incidence of scalp ringworm in
children in recent years is very apparent in the area of inner London
where I practice. Given this large increase in incidence, why are the
newer antifungal agents, such has terbinafine and itraconazole, not yet
licensed for use in children, or available in a liquid formulation that
would be easier for children to take? The pharmaceutical companies that
hold the patents for these drugs should be encouraged obtain the necessary
licences, as this would increase the range of drugs available to general
practitioners to treat scalp ringworm.

Competing interests:  
None declared

Competing interests: No competing interests

16 March 2003
Azeem Majeed
Professor of Primary Care
University College London, London WC1H 9QU